L'Oreal (LRLCY)
Market Price (11/18/2025): $0 | Market Cap: $0Sector: Consumer Staples | Industry: Household Products
L'Oreal (LRLCY)
Market Price (11/18/2025): $0Market Cap: $0Sector: Consumer StaplesIndustry: Household Products
Investment Highlights
Why It Matters
Which of these 2 stories sounds closer for this stock?
1. Generates cash flow
The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.
2. Riding a trend
Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow
| Low stock price volatilityVol 12M is 26% | Weak multi-year price returns2Y Excs Rtn is -56%, 3Y Excs Rtn is -44% | |
| Megatrend and thematic driversMegatrends include Experience Economy & Premiumization, E-commerce & Digital Retail, Sustainable Consumption, Health & Wellness Trends, Show more. |
| Low stock price volatilityVol 12M is 26% |
| Megatrend and thematic driversMegatrends include Experience Economy & Premiumization, E-commerce & Digital Retail, Sustainable Consumption, Health & Wellness Trends, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -56%, 3Y Excs Rtn is -44% |
Market Valuation & Key Metrics
LRLCY Stock
Why The Stock Moved
Stock Movement Drivers
Return vs. Risk
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| LRLCY Return | 31% | 27% | -24% | 41% | -28% | 18% | 51% |
| Peers Return | -2% | 23% | -2% | 10% | -16% | -45% | -40% |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 13% | 107% |
Monthly Win Rates [3] | |||||||
| LRLCY Win Rate | 50% | 67% | 25% | 58% | 42% | 60% | |
| Peers Win Rate | 30% | 40% | 30% | 32% | 33% | 32% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 70% | |
Max Drawdowns [4] | |||||||
| LRLCY Max Drawdown | -23% | -7% | -38% | 0% | -31% | -5% | |
| Peers Max Drawdown | -29% | -5% | -17% | -6% | -28% | -53% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: PG, ULTA, COTY, DSY, PHH.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 11/17/2025 (YTD)
How Low Can It Go
| Event | LRLCY | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -39.9% | -25.4% |
| % Gain to Breakeven | 66.5% | 34.1% |
| Time to Breakeven | 169 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -26.3% | -33.9% |
| % Gain to Breakeven | 35.7% | 51.3% |
| Time to Breakeven | 93 days | 148 days |
| 2018 Correction | ||
| % Loss | -14.2% | -19.8% |
| % Gain to Breakeven | 16.6% | 24.7% |
| Time to Breakeven | 110 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -59.6% | -56.8% |
| % Gain to Breakeven | 147.2% | 131.3% |
| Time to Breakeven | 1416 days | 1480 days |
Compare to PG, ULTA, COTY, DSY, PHH
In The Past
L'Oreal's stock fell -39.9% during the 2022 Inflation Shock from a high on 11/17/2021. A -39.9% loss requires a 66.5% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
Latest Trefis Analyses
Trade Ideas
Select past ideas related to LRLCY. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 10312025 | CLX | Clorox | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -7.8% | -7.8% | -7.8% |
| 10032025 | IPAR | Interparfums | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -7.5% | -7.5% | -7.9% |
| 09262025 | TAP | Molson Coors Beverage | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 3.6% | 3.6% | -3.6% |
| 09262025 | GIS | General Mills | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -4.2% | -4.2% | -7.1% |
| 09122025 | SMPL | Simply Good Foods | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -27.2% | -27.2% | -29.8% |
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 10312025 | CLX | Clorox | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -7.8% | -7.8% | -7.8% |
| 10032025 | IPAR | Interparfums | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -7.5% | -7.5% | -7.9% |
| 09262025 | TAP | Molson Coors Beverage | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 3.6% | 3.6% | -3.6% |
| 09262025 | GIS | General Mills | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -4.2% | -4.2% | -7.1% |
| 09122025 | SMPL | Simply Good Foods | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -27.2% | -27.2% | -29.8% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for L'Oreal
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 81.91 |
| Mkt Cap | 125.7 |
| Rev LTM | 11,655 |
| Op Inc LTM | 1,595 |
| FCF LTM | 952 |
| FCF 3Y Avg | 972 |
| CFO LTM | 1,296 |
| CFO 3Y Avg | 1,358 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 1.2% |
| Rev Chg 3Y Avg | 3.1% |
| Rev Chg Q | 3.0% |
| QoQ Delta Rev Chg LTM | 0.8% |
| Op Mgn LTM | 13.7% |
| Op Mgn 3Y Avg | 14.4% |
| QoQ Delta Op Mgn LTM | -0.1% |
| CFO/Rev LTM | 11.1% |
| CFO/Rev 3Y Avg | 12.1% |
| FCF/Rev LTM | 8.2% |
| FCF/Rev 3Y Avg | 8.7% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 125.7 |
| P/S | 2.0 |
| P/EBIT | 14.4 |
| P/E | 19.1 |
| P/CFO | 17.7 |
| Total Yield | 4.9% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | 4.7% |
| D/E | 0.1 |
| Net D/E | 0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -10.6% |
| 3M Rtn | -10.7% |
| 6M Rtn | -10.3% |
| 12M Rtn | -11.7% |
| 3Y Rtn | 13.0% |
| 1M Excs Rtn | -10.7% |
| 3M Excs Rtn | -16.0% |
| 6M Excs Rtn | -22.2% |
| 12M Excs Rtn | -21.6% |
| 3Y Excs Rtn | -52.8% |
Segment Financials
Revenue by Segment
| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Consumer Products | 15,173 | 14,021 | 12,234 | 11,704 | 12,748 |
| Luxe | 14,924 | 14,638 | 12,346 | 10,180 | 11,020 |
| Dermatological Beauty | 6,432 | 5,124 | 3,924 | 3,011 | 2,664 |
| Professional Products | 4,654 | 4,477 | 3,784 | 3,097 | 3,442 |
| Non-allocated | 0 | ||||
| Total | 41,183 | 38,261 | 32,288 | 27,992 | 29,874 |
| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Luxe | 3,332 | 3,350 | 2,816 | 2,276 | 2,494 |
| Consumer Products | 3,115 | 2,775 | 2,466 | 2,388 | 2,575 |
| Dermatological Beauty | 1,671 | 1,303 | 990 | 766 | 621 |
| Professional Products | 1,005 | 954 | 807 | 582 | 692 |
| Non-allocated | -979 | -925 | -919 | -803 | -833 |
| Total | 8,143 | 7,457 | 6,160 | 5,209 | 5,548 |
| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Luxe | 12,584 | 9,925 | 9,532 | 8,773 | 7,942 |
| Non-current financial assets | 11,632 | 11,653 | |||
| Consumer Products | 11,242 | 10,969 | 10,187 | 9,888 | 10,700 |
| Dermatological Beauty | 4,319 | 4,049 | 2,957 | 2,524 | 2,374 |
| Cash and cash equivalents | 4,288 | 2,618 | |||
| Professional Products | 3,705 | 3,512 | 3,252 | 2,963 | 3,506 |
| Other current assets | 1,915 | 2,064 | |||
| Non-allocated | 1,223 | 1,235 | 1,048 | 1,043 | 1,078 |
| Deferred tax assets | 921 | 801 | |||
| Investments accounted for under the equity method | 27 | 18 | |||
| Non-allocated assets | 16,038 | 18,417 | 18,210 | ||
| Total | 51,855 | 46,844 | 43,013 | 43,607 | 43,810 |
Returns Analyses
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
